117 related articles for article (PubMed ID: 7766018)
1. Metabolic 13C-labeling of an antitumor (1-->3)-beta-D-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395.
Suda M; Ohno N; Adachi Y; Yadomae T
Biosci Biotechnol Biochem; 1995 Feb; 59(2):203-7. PubMed ID: 7766018
[TBL] [Abstract][Full Text] [Related]
2. Preparation and properties of metabolically 3H- or 13C-labeled (1-->3)-beta-D-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395.
Suda M; Ohno N; Adachi Y; Yadomae T
Carbohydr Res; 1994 Feb; 254():213-9. PubMed ID: 8180985
[TBL] [Abstract][Full Text] [Related]
3. Two different conformations of the antitumor beta-D-glucan produced by Sclerotinia sclerotiorum IFO 9395.
Ohno N; Yadomae T
Carbohydr Res; 1987 Feb; 159(2):293-302. PubMed ID: 3567988
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
Ohno N; Kurachi K; Yadomae T
J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
[TBL] [Abstract][Full Text] [Related]
5. Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1----3)-beta-D-glucan, SSG, obtained from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.
Kurachi K; Ohno N; Yadomae T
Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2527-31. PubMed ID: 2285987
[TBL] [Abstract][Full Text] [Related]
6. The effects of a highly branched beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the growth of syngeneic tumors in mice.
Suzuki I; Hashimoto K; Yadomae T
J Pharmacobiodyn; 1988 Aug; 11(8):527-32. PubMed ID: 3236210
[TBL] [Abstract][Full Text] [Related]
7. Tissue distribution of intraperitoneally administered (1-->3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice.
Suda M; Ohno N; Adachi Y; Yadomae T
J Pharmacobiodyn; 1992 Aug; 15(8):417-26. PubMed ID: 1479542
[TBL] [Abstract][Full Text] [Related]
8. Effect of intraperitoneally administered beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the functions of murine alveolar macrophages.
Sakurai T; Suzuki I; Kinoshita A; Oikawa S; Masuda A; Ohsawa M; Yadomae T
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):214-7. PubMed ID: 2049804
[TBL] [Abstract][Full Text] [Related]
9. Gel-to-sol transition of 13C-labeled (1-->3)-beta-D-glucan, 13C-SSG, assessed by 13C nuclear magnetic resonance (13C-NMR) spectroscopy.
Suda M; Ohno N; Adachi Y; Yadomae T
Carbohydr Res; 1995 Apr; 270(1):107-13. PubMed ID: 7627986
[No Abstract] [Full Text] [Related]
10. Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1-->3)-beta-D-glucan.
Sakurai T; Kaise T; Yadomae T; Matsubara C
Eur J Pharmacol; 1997 Sep; 334(2-3):255-63. PubMed ID: 9369356
[TBL] [Abstract][Full Text] [Related]
11. Intravenously administered (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 augments murine peritoneal macrophage functions in vivo.
Sakurai T; Ohno N; Yadomae T
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2120-4. PubMed ID: 1423766
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the tissue distribution and antitumor activity of highly branched (1-->3)-beta-D-glucan, SSG.
Suda M; Ohno N; Adachi Y; Yadomae T
Biol Pharm Bull; 1994 Jan; 17(1):131-5. PubMed ID: 8148801
[TBL] [Abstract][Full Text] [Related]
13. Characterization of sodium hypochlorite degradation of beta-glucan in relation to its metabolism in vivo.
Miura NN; Ohno N; Adachi Y; Yadomae T
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2137-41. PubMed ID: 8945780
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity and structural characterization of a (1----3)-beta-D-glucan extracted with cold alkali from sclerotia of Sclerotinia sclerotiorum IFO 9395.
Shinohara H; Ohno N; Yadomae T
Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):819-23. PubMed ID: 3409388
[No Abstract] [Full Text] [Related]
15. Biosynthesis of curdlan from culture media containing 13C-labeled glucose as the carbon source.
Kai A; Ishino T; Arashida T; Hatanaka K; Akaike T; Matsuzaki K; Kaneko Y; Mimura T
Carbohydr Res; 1993 Feb; 240():153-9. PubMed ID: 8458009
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of hematopoietic response of mice by intraperitoneal administration of a beta-glucan, SSG, obtained from Sclerotinia sclerotiorum.
Hashimoto K; Suzuki I; Ohsawa M; Oikawa S; Yadomae T
J Pharmacobiodyn; 1990 Aug; 13(8):512-7. PubMed ID: 2079647
[TBL] [Abstract][Full Text] [Related]
17. Effect of soluble fungal (1-->3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation.
Sakurai T; Ohno N; Suzuki I; Yadomae T
Immunopharmacology; 1995 Aug; 30(2):157-66. PubMed ID: 8530257
[TBL] [Abstract][Full Text] [Related]
18. Structure and antitumor activity of a beta-1,3-glucan isolated from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.
Ohno N; Suzuki I; Yadomae T
Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1362-5. PubMed ID: 3731350
[No Abstract] [Full Text] [Related]
19. [Physicochemical properties of a beta-glucan from Sclerotinia sclerotiorum].
Liu R; Wang D; Yu X
Wei Sheng Wu Xue Bao; 1995 Apr; 35(2):103-8. PubMed ID: 7483576
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of Mesorhizobium huakuii cyclic beta-glucan.
Choma A; Komaniecka I
Acta Biochim Pol; 2003; 50(4):1273-81. PubMed ID: 14740013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
